| Value | ₹0.20 Cr |
|---|
BSE filing, NSE: RELTD. Summary written from the filing by ALFA Finder's alert engine.
Ravindra Energy Ltd: key numbers
- Share price
- ₹130.33
- Market cap
- ₹2,588 Cr
- Revenue (annual)
- ₹543.2 Cr
- Net profit (annual)
- ₹80.83 Cr
- P/E (TTM)
- 43.4×Sector 21.4×
- Promoter holding
- 58.26%+0.00% QoQ
- FII holding
- 3.18%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ravindra Energy Ltd
All →Ravindra Energy Employee Stock Options
Ravindra Energy allotted 500 equity shares to employees exercising options under its 2022 ESOP plan. The exercise price of Rs.100 per share totals Rs.50,000.
Ravindra Energy Price Movement Clarification
Ravindra Energy responded to an NSE volume-spike query stating no undisclosed price-sensitive information exists. The company attributed the stock movement to general market conditions.
Ravindra Energy Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) of the SEBI LODR Regulations for the quarter ended September 30, 2026.
Ravindra Energy Capital Structure Change
Director Shantanu Lath sold 13,500 equity shares of Ravindra Energy Ltd via open market transactions, reducing his holding from 0.07% to 0.06%.
- Value
- ₹0.20 Cr
Ravindra Energy Share Pledge
Ravindra Energy Limited's promoters Narendra Madhusudan Murkumbi and Khandepar Investments Private Limited pledged 8,57,000 equity shares. The pledge serves as collateral for loans from TATA Capital Limited.
Ravindra Energy Share Pledge
Promoters Khandepar Investments and Narendra Murkumbi pledged 8.57 lakh shares, valued at ₹12.69 Crore, in Ravindra Energy.
- Value
- ₹12.69 Cr
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.